05 September 2012 17:00 [Source: ICIS news]
LONDON (ICIS)--Linde has completed a €1bn ($1.2bn) bond placement to pay down a portion of the debt facility taken on to acquire US-based medical gases and respiratory healthcare firm Lincare, the German industrial gas supplier said on Wednesday.
Maturing in 2020, the bond had a coupon of 1.75% and was priced at 35 basis points over the Midswaps benchmark, with a mix of institutional and retail investors signing up to the issue.
Linde completed the acquisition of Lincare on 14 August this year, paying $41.50 per share for the Florida company. The deal was financed with $3.6bn in debt and $900m in equity, a Linde spokesperson told ICIS.
Linde's chief financial officer Georg Denoke said in a statement: "It is crucial to be able to act swiftly in a volatile market climate. We were keen to quickly replace a substantial part of the acquisition loan with long-term capital market liabilities.”
The three-times oversubscribed bond was placed under the Euro Medium Term Note (EMTN) programme, which increases the ease with which issuers can enter into foreign currency markets for capital. Linde declined to disclose bookrunners on the transaction.
($1 = €0.80)
For the latest chemical news, data and analysis that directly impacts your business sign up for a free trial to ICIS news - the breaking online news service for the global chemical industry.
Get the facts and analysis behind the headlines from our market leading weekly magazine: sign up to a free trial to ICIS Chemical Business.
|ICIS news FREE TRIAL|
|Get access to breaking chemical news as it happens.|
|ICIS Global Petrochemical Index (IPEX)|
|ICIS Global Petrochemical Index (IPEX). Download the free tabular data and a chart of the historical index|
Asian Chemical Connections